1-methyl-3-[3-(5-methyl-1(3)H-imidazol-4-ylmethylsulfanyl)-propyl]-thiourea | 52378-55-9

• 英文名称: 1-methyl-3-[3-(5-methyl-1(3)H-imidazol-4-ylmethylsulfanyl)-propyl]-thiourea
• 英文别名: N-methyl-N'-[3-((4-methyl-5-imidazolyl)methylthio)propyl]thiourea；1-methyl-3-[3-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]propyl]thiourea
• CAS: 52378-55-9
• 化学式: C₁₀H₁₈N₄S₂
• 分子量: 258.412
• InChiKey: VKRPWKLHWHTCCG-UHFFFAOYSA-N

物化性质

• 沸点：
  475.5±55.0 °C(Predicted)
• 密度：
  1.214±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  16
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  110
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-methyl-3-[3-(5-methyl-1(3)H-imidazol-4-ylmethylsulfanyl)-propyl]-thiourea 、 Lead cyanamide 以afforded N-cyano-N'-methyl-N"-[3-((4-methyl-5-imidazolyl)methylthio)propyl]guanidine (0.91 g.), m.p. 156°-158°的产率得到N-cyano-N'-methyl-N''-[3-(5-methyl-1(3)H-imidazol-4-ylmethylsulfanyl)-propyl]-guanidine
  参考文献：
  名称：

  Pharmacologically active guanidine compounds as H-2 histamine receptor

  摘要：

  这些化合物是取代的硫代烷基、氨基烷基和氧烷基胍，它们是组胺活性的抑制剂。

  公开号：

  US04070475A1

文献信息

• Pharmacologically active guanidine compounds in compositions and methods
  申请人：Smith Kline & French Laboratories Limited

  公开号：US04154844A1

  公开（公告）日：1979-05-15

  The compounds are substituted thioalkyl-, aminoalkyl- and oxyalkyl-guanidines which are inhibitors of histamine activity.

  这些化合物是替代了硫代烷基、氨基烷基和氧基烷基的胍，它们是组胺活性的抑制剂。
• Pharmacologically active guanidine compounds
  申请人：Smith Kline & French Laboratories Limited

  公开号：US03950333A1

  公开（公告）日：1976-04-13

  The compounds are substituted thioalkyl-, aminoalkyl- and oxyalkyl-guanidines which are inhibitors of histamine activity.

  这些化合物是替代了硫代烷基、氨基烷基和氧基烷基的胍，并且它们是组胺活性的抑制剂。
• Pharmacologically active guanidine compounds for inhibiting H-2
  申请人：Smith Kline & French Laboratories Limited

  公开号：US04221802A1

  公开（公告）日：1980-09-09

  The compounds are substituted thioalkyl-, aminoalkyl- and oxyalkyl-guanidines which are inhibitors of histamine activity.

  这些化合物是取代的硫代烷基、氨基烷基和氧烷基胍，它们是组胺活性的抑制剂。
• Pharmacologically active thiadiazole guanidine compounds
  申请人：Smith Kline & French Laboratories Limited

  公开号：US04228291A1

  公开（公告）日：1980-10-14

  The compounds are substituted thioalkyl-, aminoalkyl- and oxyalkyl-guanidines which are inhibitors of histamine activity.

  这些化合物是取代的硫代烷基、氨基烷基和氧烷基鸟氨酸，它们是组胺活性的抑制剂。
• N-Oxy and N-amino guanidines
  申请人：Smith Kline & French Laboratories Limited

  公开号：US04034101A1

  公开（公告）日：1977-07-05

  The compounds are N-oxy and N-amino guanidines which are histamine H.sub.2 -antagonists. A compound of this invention is N-hydroxy-N'methyl-N"-[2-((4-methyl-5-imidazolyl)methylthio)-ethyl]guanidi ne.

  这些化合物是组胺H.sub.2-拮抗剂的N-氧和N-氨基胍类化合物。本发明的一种化合物是N-羟基-N'甲基-N''-[2-((4-甲基-5-咪唑基)甲硫基)-乙基]胍。